المؤلفون: Navarro Mateu, Fernando, Quesada, Mari Paz, Escámez, Teresa, Alcaraz, María José, Seiquer de la Peña, Catherine, Salmerón, Diego, Huerta, José María, Vilagut Saiz, Gemma, 1975-, Chirlaque, María Dolores, Navarro, Carmen, Husky, Mathilde M., Kessler, Ronald C., Alonso Caballero, Jordi, Martínez, Salvador

مصطلحات موضوعية: Case-control study, Childhood adversities 5-HTTLPR polymorphism, Risk factors, Substance use disorders

وصف الملف: application/pdf

Relation: BMJ Open. 2019; 9(9):e030328; http://hdl.handle.net/10230/42379

الاتاحة: http://hdl.handle.net/10230/42379
https://doi.org/10.1136/bmjopen-2019-030328

المؤلفون: Navarro-Mateu, Fernando, Quesada, Mari Paz, Escámez, Teresa, Alcaráz, Mª José, Seiquer de la Peña, Catherine, Salmerón, Diego, Huerta, José María, Vilagut, Gemma, Chirlaque, Maria Dolores, Navarro, Carmen, Husky, Mathilde M., Kessler, Ronald C., Alonso, Jordi, Martínez, Salvador

المساهمون: Gobierno de la Región de Murcia, Harvard University, University of Michigan, National Institute on Mental Health (US), John D. and Catherine T. MacArthur Foundation, Pfizer, National Institutes of Health (US), Eli Lilly and Company, GlaxoSmithKline, Bristol-Myers Squibb

مصطلحات موضوعية: Childhood adversities 5-HTTLPR polymorphism, Substance use disorders, Case-control study, Risk factors

Relation: Publisher's version; https://doi.org/10.1136/ bmjopen-2019-030328; Sí; BMJ Open 9(9): e030328 (2019); http://hdl.handle.net/10261/217713; http://dx.doi.org/10.13039/100007229; http://dx.doi.org/10.13039/100002491; http://dx.doi.org/10.13039/100004312; http://dx.doi.org/10.13039/100004330; http://dx.doi.org/10.13039/100000002; http://dx.doi.org/10.13039/100004319; http://dx.doi.org/10.13039/100007270; http://dx.doi.org/10.13039/501100009569

الاتاحة: http://hdl.handle.net/10261/217713
https://doi.org/10.13039/100007229
https://doi.org/10.13039/100002491
https://doi.org/10.13039/100004312
https://doi.org/10.13039/100004330
https://doi.org/10.13039/100000002
https://doi.org/10.13039/100004319
https://doi.org/10.13039/100007270
https://doi.org/10.13039/501100009569

المؤلفون: Gobierno de la Región de Murcia, Harvard University, University of Michigan, National Institute of Mental Health (US), John D. and Catherine T. MacArthur Foundation, Pfizer, National Institutes of Health (US), Eli Lilly and Company, GlaxoSmithKline, Bristol-Myers Squibb, Navarro-Mateu, Fernando, Quesada, Mari Paz, Escámez, Teresa, Alcaráz, Mª José, Seiquer de la Peña, Catherine, Salmerón, Diego, Huerta, José María, Vilagut, Gemma, Chirlaque, Maria Dolores, Navarro, Carmen, Husky, Mathilde M., Kessler, Ronald C., Alonso, Jordi, Martínez, Salvador

مصطلحات الفهرس: Childhood adversities 5-HTTLPR polymorphism, Substance use disorders, Case-control study, Risk factors, artículo

URL: http://hdl.handle.net/10261/217713
https://doi.org/10.1136/bmjopen-2019-030328
Publisher's version
https://doi.org/10.1136/ bmjopen-2019-030328
Sí